Impact of timing to initiate adjuvant therapy on survival of elderly glioblastoma patients using the SEER-Medicare and national cancer databases.

Zhu, Ping; Du, Xianglin L; Hwang, Lu-Yu; Lairson, David; Li, Ruosha; Esquenazi, Yoshua; Zhu, Jay-Jiguang

Zhu, Ping; Du, Xianglin L; Hwang, Lu-Yu; Lairson, David; Li, Ruosha; Esquenazi, Yoshua; Zhu, Jay-Jiguang.

Afiliación

Zhu P; The Vivian L. Smith Department of Neurosurgery, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX, USA.
Du XL; Epidemiology, Human Genetics and Environmental Sciences, UTHealth School of Public Health, Houston, TX, USA.
Hwang LY; Epidemiology, Human Genetics and Environmental Sciences, UTHealth School of Public Health, Houston, TX, USA.
Lairson D; Epidemiology, Human Genetics and Environmental Sciences, UTHealth School of Public Health, Houston, TX, USA.
Li R; Department of Management, Policy, and Community Health, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Esquenazi Y; Department of Biostatistics and Data Science, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Zhu JJ; The Vivian L. Smith Department of Neurosurgery, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX, USA.

Sci Rep ; 13(1): 3266, 2023 02 25.

Article en En | MEDLINE | ID: mdl-36841851

Asunto(s)

Glioblastoma; Humanos; Anciano; Estados Unidos; Medicare; Terapia Combinada; Análisis de Supervivencia; Modelos de Riesgos Proporcionales; Programa de VERF; Estimación de Kaplan-Meier

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Glioblastoma Tipo de estudio: Prognostic_studies Límite: Aged / Humans País/Región como asunto: America do norte Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google